Shea MK et al. |
Vitamin K supplementation and progression of coronary artery calcium in older men and women. |
2009 |
Am. J. Clin. Nutr. |
pmid:19386744
|
Guañabens N et al. |
High osteoprotegerin serum levels in primary biliary cirrhosis are associated with disease severity but not with the mRNA gene expression in liver tissue. |
2009 |
J. Bone Miner. Metab. |
pmid:19229472
|
Sun J et al. |
Proliferation and gene expression of osteoblasts cultured in DMEM containing the ionic products of dicalcium silicate coating. |
2009 |
Biomed. Pharmacother. |
pmid:19231130
|
Bylski D et al. |
Alumina ceramic particles, in comparison with titanium particles, hardly affect the expression of RANK-, TNF-alpha-, and OPG-mRNA in the THP-1 human monocytic cell line. |
2009 |
J Biomed Mater Res A |
pmid:18449944
|
Watanabe Y et al. |
IL-1beta suppresses the formation of osteoclasts by increasing OPG production via an autocrine mechanism involving celecoxib-related prostaglandins in chondrocytes. |
2009 |
Mediators Inflamm. |
pmid:20204061
|
Ominsky MS et al. |
One year of transgenic overexpression of osteoprotegerin in rats suppressed bone resorption and increased vertebral bone volume, density, and strength. |
2009 |
J. Bone Miner. Res. |
pmid:19257823
|
Biosse-Duplan M et al. |
Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts. |
2009 |
Am. J. Pathol. |
pmid:19264900
|
West SL et al. |
The effect of exercise and estrogen on osteoprotegerin in premenopausal women. |
2009 |
Bone |
pmid:18929691
|
Tada T et al. |
Oral squamous cell carcinoma cells modulate osteoclast function by RANKL-dependent and -independent mechanisms. |
2009 |
Cancer Lett. |
pmid:18930344
|
Wasilewska A et al. |
Serum osteoprotegrin (OPG) and receptor activator of nuclear factor kappaB (RANKL) in healthy children and adolescents. |
2009 |
J. Pediatr. Endocrinol. Metab. |
pmid:20333868
|
Moran CS et al. |
Interaction between angiotensin II, osteoprotegerin, and peroxisome proliferator-activated receptor-gamma in abdominal aortic aneurysm. |
2009 |
J. Vasc. Res. |
pmid:18931513
|
Flint J et al. |
Relationships between osteoprotegerin (OPG), receptor activator of nuclear factor kappaB ligand (RANKL), and growth hormone (GH) secretory status in short children. |
2009 |
J. Pediatr. Endocrinol. Metab. |
pmid:20333869
|
Schofer MD et al. |
Influence of nanofibers on the growth and osteogenic differentiation of stem cells: a comparison of biological collagen nanofibers and synthetic PLLA fibers. |
2009 |
J Mater Sci Mater Med |
pmid:18987945
|
Xu M et al. |
Low-intensity pulsed laser irradiation affects RANKL and OPG mRNA expression in rat calvarial cells. |
2009 |
Photomed Laser Surg |
pmid:18800943
|
Nishiura R et al. |
Elevated osteoprotegerin levels predict cardiovascular events in new hemodialysis patients. |
2009 |
Am. J. Nephrol. |
pmid:18802328
|
Norian JM et al. |
Low serum osteoprotegerin levels in premenopausal infertile women with low bone density: an association of relevance? |
2009 |
Fertil. Steril. |
pmid:18490014
|
Whitney MJ et al. |
Leukemia inhibitory factor secretion is a predictor and indicator of early progenitor status in adult bone marrow stromal cells. |
2009 |
Tissue Eng Part A |
pmid:18637760
|
Kiechl S et al. |
Denosumab, osteoporosis, and prevention of fractures. |
2009 |
N. Engl. J. Med. |
pmid:19940304
|
Gürkan A et al. |
Therapeutic efficacy of vasoactive intestinal peptide in escherichia coli lipopolysaccharide-induced experimental periodontitis in rats. |
2009 |
J. Periodontol. |
pmid:19792856
|
Spencer AY and Lallier TE |
Mechanical tension alters semaphorin expression in the periodontium. |
2009 |
J. Periodontol. |
pmid:19792857
|
Greiner S et al. |
Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating. |
2009 |
J Biomed Mater Res A |
pmid:18980195
|
Harinarayan CV |
Crohn's disease & osteoimmunology--is vitamin D the cross-talk co-ordinator? |
2009 |
Indian J. Med. Res. |
pmid:19797805
|
Katopodis H et al. |
MG-63 osteoblast-like cells enhance the osteoprotegerin expression of PC-3 prostate cancer cells. |
2009 |
Anticancer Res. |
pmid:19846944
|
Trombone AP et al. |
Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection. |
2009 |
J. Periodont. Res. |
pmid:18973535
|
Sanchez C et al. |
Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts. |
2009 |
Osteoarthr. Cartil. |
pmid:18974013
|
Chanda D et al. |
Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in prostate cancer bone metastasis. |
2009 |
Clin. Cancer Res. |
pmid:19920103
|
Hozumi A et al. |
Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation. |
2009 |
Biochem. Biophys. Res. Commun. |
pmid:19324007
|
Kaunitz AM et al. |
Postmenopausal osteoporosis: fracture risk and prevention. |
2009 |
J Fam Pract |
pmid:19891943
|
Semb AG et al. |
Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19325145
|
Panizo S et al. |
RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. |
2009 |
Circ. Res. |
pmid:19325147
|
Palazzuoli A et al. |
Osteoprotegerin and B-type natriuretic peptide in acute coronary syndromes with preserved systolic function: relation to coronary artery disease extension. |
2009 |
Int. J. Cardiol. |
pmid:18707771
|
Reid P and Holen I |
Pathophysiological roles of osteoprotegerin (OPG). |
2009 |
Eur. J. Cell Biol. |
pmid:18707795
|
Kanzaki S et al. |
Bisphosphonate therapy ameliorates hearing loss in mice lacking osteoprotegerin. |
2009 |
J. Bone Miner. Res. |
pmid:18715136
|
Atkins GJ et al. |
Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. |
2009 |
Osteoporos Int |
pmid:18763010
|
Ota N et al. |
Accelerated cartilage resorption by chondroclasts during bone fracture healing in osteoprotegerin-deficient mice. |
2009 |
Endocrinology |
pmid:19819969
|
Dunn IC et al. |
New hypotheses on the function of the avian shell gland derived from microarray analysis comparing tissue from juvenile and sexually mature hens. |
2009 |
Gen. Comp. Endocrinol. |
pmid:19303879
|
Tan L et al. |
Osteoprotegerin and ligand of receptor activator of nuclear factor kappaB expression in ovariectomized rats during tooth movement. |
2009 |
Angle Orthod |
pmid:19216604
|
Nuche-Berenguer B et al. |
Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states. |
2009 |
Calcif. Tissue Int. |
pmid:19219381
|
Baud'huin M et al. |
Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival. |
2009 |
J. Biol. Chem. |
pmid:19758994
|
Rifas L and Weitzmann MN |
A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner. |
2009 |
Arthritis Rheum. |
pmid:19877052
|
Bargnoux AS et al. |
Evolution of coronary artery calcifications following kidney transplantation: relationship with osteoprotegerin levels. |
2009 |
Am. J. Transplant. |
pmid:19775319
|
Dalle Carbonare L et al. |
Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. |
2009 |
Arthritis Rheum. |
pmid:19877060
|
Krajewski AC et al. |
Influence of lipopolysaccharide and interleukin-6 on RANKL and OPG expression and release in human periodontal ligament cells. |
2009 |
APMIS |
pmid:19775343
|
Hamed AA and Fayad JN |
Presence of otosclerosis and paget lesions in the same temporal bone. |
2009 |
Otol. Neurotol. |
pmid:19779387
|
Golledge J et al. |
A single-nucleotide polymorphism in the gene encoding osteoprotegerin is associated with diastolic blood pressure in older men. |
2009 |
Am. J. Hypertens. |
pmid:19779468
|
Schett G et al. |
Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis. |
2009 |
Arthritis Rheum. |
pmid:19714640
|
Kim CH et al. |
Effects of high frequency loading on RANKL and OPG mRNA expression in ST-2 murine stromal cells. |
2009 |
BMC Musculoskelet Disord |
pmid:19728893
|
Cozzolino M |
Emerging roles for osteoprotegerin and receptor activator of nuclear factor-kappaB in the vascular system. |
2009 |
Blood Purif. |
pmid:19729903
|
Anandarajah AP and Schwarz EM |
Bone loss in the spondyloarthropathies: role of osteoclast, RANKL, RANK and OPG in the spondyloarthropathies. |
2009 |
Adv. Exp. Med. Biol. |
pmid:19731622
|
Shargorodsky M et al. |
Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women. |
2009 |
Atherosclerosis |
pmid:19062016
|
Ryser MD et al. |
Mathematical modeling of spatio-temporal dynamics of a single bone multicellular unit. |
2009 |
J. Bone Miner. Res. |
pmid:19063683
|
Kadow-Romacker A et al. |
Effect of mechanical stimulation on osteoblast- and osteoclast-like cells in vitro. |
2009 |
Cells Tissues Organs (Print) |
pmid:19033679
|
Rauner M et al. |
The HLA-B27 transgenic rat, a model of spondyloarthritis, has decreased bone mineral density and increased RANKL to osteoprotegerin mRNA ratio. |
2009 |
J. Rheumatol. |
pmid:19040304
|
Buijs JT et al. |
Inhibition of bone resorption and growth of breast cancer in the bone microenvironment. |
2009 |
Bone |
pmid:19041433
|
Giner M et al. |
RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis. |
2009 |
J. Steroid Biochem. Mol. Biol. |
pmid:19073256
|
Zauli G et al. |
Role of full-length osteoprotegerin in tumor cell biology. |
2009 |
Cell. Mol. Life Sci. |
pmid:19011755
|
Kostenuik PJ et al. |
Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL. |
2009 |
J. Bone Miner. Res. |
pmid:19016581
|
Yasuhara R et al. |
Lysine-specific gingipain promotes lipopolysaccharide- and active-vitamin D3-induced osteoclast differentiation by degrading osteoprotegerin. |
2009 |
Biochem. J. |
pmid:19102726
|
Lee JS et al. |
Changes in serum levels of receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, IL-6 and TNF-alpha in patients with a concomitant head injury and fracture. |
2009 |
Arch Orthop Trauma Surg |
pmid:18427820
|
Mohamed JA et al. |
A single-nucleotide polymorphism in the gene encoding osteoprotegerin, an anti-inflammatory protein produced in response to infection with diarrheagenic Escherichia coli, is associated with an increased risk of nonsecretory bacterial diarrhea in North American travelers to Mexico. |
2009 |
J. Infect. Dis. |
pmid:19128145
|
Graciolli FG et al. |
Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia. |
2009 |
Nephrol. Dial. Transplant. |
pmid:19075196
|
Turk N et al. |
Proinflammatory cytokines and receptor activator of nuclear factor kappaB-ligand/osteoprotegerin associated with bone deterioration in patients with Crohn's disease. |
2009 |
Eur J Gastroenterol Hepatol |
pmid:19098682
|
McGonigle JS et al. |
Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function. |
2009 |
Angiogenesis |
pmid:19105036
|
Kwok SK et al. |
Circulating osteoprotegerin levels are elevated and correlated with antiphospholipid antibodies in patients with systemic lupus erythematosus. |
2009 |
Lupus |
pmid:19151114
|
Ren W et al. |
Effect of oral erythromycin therapy in patients with aseptic loosening of joint prostheses. |
2009 |
Bone |
pmid:19154802
|
Chiba Y et al. |
Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women. |
2009 |
Gerontology |
pmid:19158438
|
Sims TL et al. |
Neural progenitor cell-mediated delivery of osteoprotegerin limits disease progression in a preclinical model of neuroblastoma bone metastasis. |
2009 |
J. Pediatr. Surg. |
pmid:19159744
|
Madarász E et al. |
Osteoprotegerin levels in women with prior gestational diabetes mellitus. |
2009 |
Diabetes Care |
pmid:19114622
|
Yun HJ et al. |
Adrenomedullin inhibits MAPK pathway-dependent rheumatoid synovial fibroblast-mediated osteoclastogenesis by IL-1 and TNF-alpha. |
2009 |
Rheumatol. Int. |
pmid:19116717
|
Murthy RK et al. |
Bone biology and the role of the RANK ligand pathway. |
2009 |
Oncology (Williston Park, N.Y.) |
pmid:20128323
|
Stanisławowski M and Kmieć Z |
[The participation of RANK, RANKL and OPG in tumor osteolysis]. |
2009 |
Postepy Hig Med Dosw (Online) |
pmid:19502684
|
Fahrleitner-Pammer A et al. |
The effect of RANKL and OPG on bone mineral density in pre-dialysis chronic renal failure. |
2009 |
Clin. Nephrol. |
pmid:19473634
|
Hazenberg JG et al. |
Microdamage detection and repair in bone: fracture mechanics, histology, cell biology. |
2009 |
Technol Health Care |
pmid:19478407
|
Morena M et al. |
A cut-off value of plasma osteoprotegerin level may predict the presence of coronary artery calcifications in chronic kidney disease patients. |
2009 |
Nephrol. Dial. Transplant. |
pmid:19574342
|
Schnabel RB et al. |
Relation of multiple inflammatory biomarkers to incident atrial fibrillation. |
2009 |
Am. J. Cardiol. |
pmid:19576326
|
Geusens P |
Emerging treatments for postmenopausal osteoporosis - focus on denosumab. |
2009 |
Clin Interv Aging |
pmid:19554095
|
Sampaio MS et al. |
Expression of eight genes of nuclear factor-kappa B pathway in multiple myeloma using bone marrow aspirates obtained at diagnosis. |
2009 |
Histol. Histopathol. |
pmid:19554506
|
Booij-Vrieling HE et al. |
Inflammatory cytokines and the nuclear vitamin D receptor are implicated in the pathophysiology of dental resorptive lesions in cats. |
2009 |
Vet. Immunol. Immunopathol. |
pmid:19556012
|
Anastasilakis AD et al. |
RANKL inhibition for the management of patients with benign metabolic bone disorders. |
2009 |
Expert Opin Investig Drugs |
pmid:19558335
|
Yongchaitrakul T et al. |
Osteoprotegerin induces osteopontin via syndecan-1 and phosphoinositol 3-kinase/Akt in human periodontal ligament cells. |
2009 |
J. Periodont. Res. |
pmid:19602124
|
Ovchinnikova O et al. |
Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice--brief report. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19592469
|
Gupta S et al. |
Newer biomarkers in heart failure. |
2009 |
Heart Fail Clin |
pmid:19631181
|
Alonso V et al. |
Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells. |
2009 |
Life Sci. |
pmid:19632246
|
Sauer AV et al. |
ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency. |
2009 |
Blood |
pmid:19633200
|
Narducci P et al. |
Interaction of human recombinant tumor necrosis factor-related apoptosis-inducing ligand and osteoprotegerin could contribute to enhancement of the erosive processes induced by human synovial cells. |
2009 |
J. Rheumatol. |
pmid:19671825
|
Patiño-GarcÃa A et al. |
Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. |
2009 |
Clin. Cancer Res. |
pmid:19671856
|
Spahni AI et al. |
Immunohistochemical localization of RANK, RANKL and OPG in healthy and arthritic canine elbow joints. |
2009 |
Vet Surg |
pmid:19674422
|
Mesquita M et al. |
Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease. |
2009 |
Clin. Chem. Lab. Med. |
pmid:19676147
|
Kiani AN et al. |
Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. |
2009 |
J. Rheumatol. |
pmid:19648301
|
Lappin DF et al. |
Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus. |
2009 |
J. Clin. Periodontol. |
pmid:19624408
|
Yokoyama M et al. |
Dynamic changes in bone metabolism in the rat temporomandibular joint after molar extraction using bone scintigraphy. |
2009 |
Eur. J. Oral Sci. |
pmid:19627347
|
Voskaridou E et al. |
Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration. |
2009 |
Haematologica |
pmid:19407319
|
Sotillo Rodriguez JE et al. |
Enhanced osteoclastogenesis causes osteopenia in twisted gastrulation-deficient mice through increased BMP signaling. |
2009 |
J. Bone Miner. Res. |
pmid:19419314
|
Yamaguchi M |
RANK/RANKL/OPG during orthodontic tooth movement. |
2009 |
Orthod Craniofac Res |
pmid:19419454
|
Neves JS et al. |
Immunolocalization of CSF-1, RANKL and OPG in the enamel-related periodontium of the rat incisor and their implications for alveolar bone remodeling. |
2009 |
Arch. Oral Biol. |
pmid:19419711
|
Gasowska K et al. |
The influence of unfractionated and low-molecular weight heparins on the properties of human umbilical vein endothelial cells (HUVEC). |
2009 |
Folia Histochem. Cytobiol. |
pmid:19419932
|
Ali Z et al. |
Association of serum osteoprotegerin with ankle-brachial index and urine albumin: creatinine ratio in African-Americans and non-Hispanic whites. |
2009 |
Atherosclerosis |
pmid:19423112
|
Alexander MY |
RANKL links arterial calcification with osteolysis. |
2009 |
Circ. Res. |
pmid:19423860
|
Nakamura M et al. |
[Osteoclastogenesis and bone resorption]. |
2009 |
Nippon Rinsho |
pmid:19432105
|
Masuda H and Tanaka S |
[Drugs under development for osteoporosis ]. |
2009 |
Nippon Rinsho |
pmid:19432120
|